A new study examined the impact of cannabis use on driving performance in older adults who were regular cannabis users.
As noted in a recently published study, though cannabis use is increasing in older adults and studies have shown that cannabis consumption increases the risk of collisions, there is a lack of studies examining the how cannabis consumption in older adults affects their driving (1). Based on this, researchers in Canada intended to study the relationship between “retail cannabis available to the consumer, driving, and associated blood tetrahydrocannabinol (THC) levels in people over 65 years of age” (1). In the introduction to their study, “Cannabis and Driving in Older Adults,” researchers also noted that THC limits are used in driving impairment tests, though there is still some debate over their effectiveness, plus the possibility of THC tolerance in older cannabis users (1). The study was published in JAMA Network Open on January 18, 2024 (1).
In this study, 31 participants, who used cannabis regularly and were between the ages of 65 and 79, operated a driving simulator before and after smoking cannabis of their choice—most cannabis samples were dominant in tetrahydrocannabinol (THC) and contained some cannabidiol (CBD) (1). Researchers tracked their speed, weaving, and reaction time and also measured THC and CBD metabolites in participants’ blood (1).
Researchers observed that weaving increased and speed decreased at 30 minutes after smoking cannabis but not after 180 minutes compared to the control conditions (1). Some of the other notable findings mentioned in the abstract also state (1):
The findings addressed the effects of cannabis, even a regularly used product, on driving. “The present study provides an ecologically valid demonstration that cannabis can impair driving in older adults when they smoke their usual product,” the authors concluded (1). “Consistent with emerging data, blood THC level was not correlated with driving behavior. Older drivers should refrain from using cannabis when contemplating operation of a motor vehicle.”
The study was conducted between March and November 2022 and funded by Transport Canada Enhanced Road Safety Transfer Payment Program (1).
Read more recent coverage on cannabis and older adults.
Reference
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.